These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26919451)

  • 61. Greenlight™ photovaporization of the prostate in patients under rivaroxaban: Lesson learned after the first cases.
    Charbonneau H; Pathak A; Albenque JP; Misrai V
    Prog Urol; 2016 Apr; 26(5):273-5. PubMed ID: 26970929
    [No Abstract]   [Full Text] [Related]  

  • 62. Prophylactic subcutaneous heparin therapy as a cause of bilateral adrenal hemorrhage.
    Hardwicke MB; Kisly A
    Arch Intern Med; 1992 Apr; 152(4):845-7. PubMed ID: 1558445
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fatal intracerebral bleeding under rivaroxaban.
    Stöllberger C; Bastovansky A; Finsterer J
    Int J Cardiol; 2015 Dec; 201():110-2. PubMed ID: 26296048
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Single-Dose Rivaroxaban-Induced Acute Liver Injury.
    Verheyen E; Kileci JA; Mathew JP
    Am J Ther; 2019; 26(4):e538-e540. PubMed ID: 29889676
    [No Abstract]   [Full Text] [Related]  

  • 65. "Bite-sized" rivaroxaban patient education and its effect on knowledge.
    Sedlacek J; Giuliano CA; Baisden K; Lipari M
    Int J Clin Pharm; 2019 Feb; 41(1):6-8. PubMed ID: 30515711
    [No Abstract]   [Full Text] [Related]  

  • 66. The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study.
    Haas S; Holberg G; Kreutz R; Lassen MR; Mantovani L; Haupt V; Vogtländer K; Turpie AG
    Vasc Health Risk Manag; 2016; 12():209-18. PubMed ID: 27274266
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bilateral adrenal hemorrhage after anticoagulation prophylaxis for bilateral knee arthroplasty.
    LaBan MM; Whitmore CE; Taylor RS
    Am J Phys Med Rehabil; 2003 May; 82(5):418-20. PubMed ID: 12704285
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of rivaroxaban in the prevention of atherosclerotic events.
    Sanmartín M; Bellmunt S; Cosín-Sales J; García-Moll X; Riera-Mestre A; Almendro-Delia M; Hernández JL; Lozano F; Mazón P; Suarez Fernández C
    Expert Rev Clin Pharmacol; 2019 Aug; 12(8):771-780. PubMed ID: 31269825
    [No Abstract]   [Full Text] [Related]  

  • 69. The impact of low-dose anticoagulation therapy on peripheral artery disease: insights from the VOYAGER trial.
    Fukaya E; Leeper NJ
    Cardiovasc Res; 2020 Oct; 116(12):e156-e158. PubMed ID: 32980875
    [No Abstract]   [Full Text] [Related]  

  • 70. Rivaroxaban and retropharyngeal haemorrhage.
    McCarter JA; Bell PR; McCadden L; Scally C
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26884072
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adrenal crisis due to bilateral adrenal hemorrhage in primary antiphospholipid syndrome.
    Ringkananon U; Khovidhunkit W; Vongthavaravat V; Sridama V; Lalitanantpong S; Snabboon T
    J Med Assoc Thai; 2005 Apr; 88(4):534-7. PubMed ID: 16146261
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Bilateral adrenal hemorrhage with adrenal insufficiency in the framework of primary antiphospholipid antibody syndrome].
    Stricker H; Bertini F; Mombelli G
    Schweiz Med Wochenschr; 2000 Apr; 130(17):625-8. PubMed ID: 10829300
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].
    Meddahi S; Samama MM
    J Mal Vasc; 2014 May; 39(3):183-94. PubMed ID: 24650612
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rivaroxaban in acute coronary syndromes--is it prime time?
    Asrar ul Haq M; van Gaal WJ
    Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):649-58. PubMed ID: 24746010
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study.
    Agnelli G; Gallus A; Goldhaber SZ; Haas S; Huisman MV; Hull RD; Kakkar AK; Misselwitz F; Schellong S;
    Circulation; 2007 Jul; 116(2):180-7. PubMed ID: 17576867
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bilateral adrenal hemorrhage during ACTH treatment of ulcerative colitis. Report of a case and review of the literature.
    Marcus HI; Connon JJ; Stern HS
    Dis Colon Rectum; 1986 Feb; 29(2):130-2. PubMed ID: 3002734
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Efficacy of using rivaroxaban for treatment of heat-induced thrombosis after endovenous laser ablation].
    Fokin AA; Borsuk DA; Kazachkov EL
    Angiol Sosud Khir; 2016; 22(4):97-101. PubMed ID: 27935887
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Probable Rivaroxaban-Induced Full Body Rash: A Case Report.
    Sasson E; James M; Russell M; Todorov D; Cohen H
    J Pharm Pract; 2018 Oct; 31(5):503-506. PubMed ID: 28803520
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rivaroxaban-Induced Gastrointestinal Bleeding Presenting as Acute Colon Obstruction.
    Cohen M; Nevo H; Hershko D; Becker A
    Pharmacology; 2017; 99(3-4):124-127. PubMed ID: 27988509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.